Literature DB >> 2793239

Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies.

C Fahrer1, R Brachmann, K von der Helm.   

Abstract

Six biopsies (4 of human fibrosarcomas, 1 of a B-cell lymphoma and 1 of a normal lymph node from a melanoma patient) and 6 cell lines (derived from 5 different human osteosarcomas and from 1 rhabdomyosarcoma), together with control cells, were examined for the expression of c-sis, c-fos and c-myc. The expression of c-sis/PDGF-B-related proteins was also examined in cultured cells (not in biopsies). In situ hybridization studies further showed that the occurrence and level of expression of c-sis mRNA and c-sis/PDGF-B-related proteins were significant in the tumor cells. Expression of c-fos and c-myc mRNA did not correlate with c-sis expression. Southern blot analysis of c-sis, c-fos and c-myc of 20 DNAs of cell lines derived from human sarcoma or biopsies showed an identical pattern for BamH1 and EcoR1 restriction fragments of c-sis (except for 1 fibrosarcoma biopsy), implicating no gene rearrangement as a cause of enhanced proto-oncogene expression. The nucleotide sequence of c-sis is highly homologous to that of the viral v-sis oncogene which is capable of transforming infected cells. We conclude that enhanced expression of c-sis in the sarcomas we have examined is involved in the initiation and/or maintenance of the cell transformed state.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793239     DOI: 10.1002/ijc.2910440416

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin.

Authors:  A Smits; K Funa; F S Vassbotn; M Beausang-Linder; F af Ekenstam; C H Heldin; B Westermark; M Nistér
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

2.  Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.

Authors:  K Scotlandi; N Baldini; M Oliviero; M F Di Renzo; M Martano; M Serra; M C Manara; P M Comoglio; R Ferracini
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 3.  Chemotherapy for metastatic soft tissue sarcomas--another full circle?

Authors:  V H Bramwell
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

Review 4.  Molecular targets in therapy for human soft-tissue and bone sarcomas.

Authors:  Dejka M Steinert; L Johnetta Blakely; Jason Salganick; Jonathan C Trent
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.